Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Speculator’s Watch List: 7 Stocks Ripe for a Short-Squeeze Windfall

By Josh Enomoto, InvestorPlace Contributor

Although betting against the bears is risky, the rewards for targeting short-squeeze stocks can also be stratospheric.

3 Stocks to Buy that Could Piggyback off of Nvidia’s Success

By Josh Enomoto, InvestorPlace Contributor

While we all love, or at least come away impressed with semiconductor juggernaut Nvidia (NASDAQ:NVDA), it’s difficult not to notice the obvious: Nvidia stock is…

Risk and Reward: 3 Bank Stocks for the Bold Investor

By Josh Enomoto, InvestorPlace Contributor

After navigating the crisis earlier this year that roiled regional bank stocks, the coast is clear to dive into this sector, right? Well, not quite.…

Economic Armor: 7 Defensive Consumer Stocks to Weather Any Storm

By Josh Enomoto, InvestorPlace Contributor

To be completely upfront, defensive consumer stocks tend to be incredibly boring. With these ideas, you’re almost giving up any practical intentions of robustly beating…

5 Investors Betting Big on RedHill Biopharma (RDHL) Stock

By Josh Enomoto, InvestorPlace Contributor

Although incredibly risky, RedHill Biopharma skyrocketed on an FDA exclusivity grant, thus warranting another look at RDHL stock.

Load More